Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Katharine A. Rendle, PhD, MSW, MPH

Associate Professor of Family Medicine and Community Health
Full Member, Abramson Cancer Center, Cancer Control Program
Senior Fellow, Leonard Davis Institute
Director of Cancer Implementation Research, Penn Implementation Science Center (PISCE)
Director, Penn Center for Cancer Care Innovation (PC3I), Abramson Cancer Center
Department: Family Medicine and Community Health

Contact information
Department of Family Medicine and Community Health
3600 Civic Center Blvd, 8th Floor
Philadelphia, PA 19104
Office: 215-349-5442
Education
BA (Anthropology)
University of California, 2004.
MSW (Social Policy & Evaluation)
University of Michigan, 2007.
MA (Anthropology)
University of Michigan, 2008.
PhD (Social Work & Anthropology)
University of Michigan, 2014.
MPH (Epidemiology)
University of California, 2015.
Post-Graduate Training
Public Health Intern, Washtenaw County Public Health Department (Ypsilanti, MI), 2006-2006.
Health Policy Intern, Children Now (Oakland, CA), 2006-2006.
Postdoctoral Fellow, Cancer Prevention Fellowship Program, National Cancer Institute/National Institutes of Health, 2014-2017.
Trainee, Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC), National Cancer Institute/National Institutes of Health, 2018-2018.
Trainee, NCI Multilevel Intervention Training Institute (MLTI), National Cancer Institute/National Institutes of Health, 2020-2020.
Certifications
Multicultural Classroom Facilitation; Center for Research on Learning and Teaching; University of Michigan , 2008.
NCI Summer Curriculum in Cancer Prevention; National Cancer Institute, National Institutes of Health , 2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

cancer prevention and care; healthcare delivery research; implementation science; mixed-methods research; clinical epidemiology; pragmatic trials; global health

Selected Publications

Del Vecchio NJ, Doria-Rose VP, Todd KW, Rendle KA, Chubak J, Halm EA, Alonge OD, Issaka RB, Neslund-Dudas C, Honda S, Ziebell RA, Li CI, Zheng Y, Hughes AE, Ritzwoller DP, Corley DA.: Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic. Cancer Epidemiol Biomarkers Prev 35: 1527-1534, Sep 2026.

Kim RY, Gupta A, Ang L, Rendle KA.: Contemporary Pulmonary Nodule Evaluation and Management in the United States A Mixed-Methods Study. Chest Jul 2026.

Oshiro CE, Cushing-Haugen KL, Vecchio NJD, Alonge OD, Ghai NR, Green BB, Honda SA, Neslund-Dudas C, Ritzwoller DP, Skinner CS, Tao M, Vachani A, Chubak J, Corley DA, Haas JS, Li CI, Tiro JA, Rendle KA.: BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population. Am J Prev Med 71: 108434, May 2026.

De Jesus E, Woo S, Krouse RS, Guerra CE, Rendle KA, Cadet T, Allison KC, Tchou J.: A community based participatory research approach to evaluate barriers and facilitators for behavioral weight loss intervention implementation in a predominantly black community. Support Care Cancer 34: 406, Apr 2026.

Kim RY, Gupta A, Ang L, Bilger A, Vachani A, Rendle KA.: Clinicians' cancer risk assessment among patients with pulmonary nodules: a qualitative study. Ann Am Thorac Soc 23: 458-463, Mar 2026.

Pocobelli G, Del Vecchio NJ, Cushing-Haugen K, Kamineni A, Corley DA, Rendle KA, Halm EA, Li CI, Oshiro CES, Carroll NM, Silver MI, Greenlee RT, Neslund-Dudas C, Breslau ES, Chubak J.: Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening. J Natl Cancer Inst Feb 2026.

Burnett-Hartman AN, Carroll NM, Wain KF, Hixon BP, Vachani A, Greenlee RT, Honda SA, Kim RY, Neslund-Dudas C, Oshiro CES, Rendle KA, Simoff M, Ritzwoller DP.: Lung Cancer Yield by Baseline Screening Lung CT Screening Reporting and Data System (Lung-RADS) Assignment and Patient Factors: The Population-Based Research to Optimize the Screening Process Lung Consortium. CHEST Pulm 2026.

George J, Amoo-Mitchual S, Kernell C, Tuli S, Patel P, Monare B, Kassick M, Ketlametswe R, Seiphetlheng A, Tafadzwa M, Sughra H, Oyegoke WTE, Ramontshonyana G, Oliva Díaz JA, Bazzett-Matabele L, Vuylsteke P, Rendle KA, Grover S.: Adherence to Survivorship Care Visits in Patients With Cervical Cancer in Botswana. JCO Glob Oncol 2026 Notes: Rendle and Grover Co-Senior Authors.

Tortorello GN, Shafique N, De Jesus EM, Gimotty P, Dheer A, Fayanju OM, Tchou J, Miura JT, Karakousis GC, Rendle K.: Sentinel Lymph Node Biopsy in Low-Risk Breast Cancer in Patients ≥ 70 Years: How Wisely are We Choosing? Ann Surg Oncol 2026.

Wittner V, Purcell J, Cayabyab M, Hoffecker G, Kalman J, Teitelbaum U, Schnoll R, Rendle KA, Tuteja S.: Patient and provider perspectives on the implementation of DPYD testing in oncology care clinics in an academic health system. J Am Pharm Assoc (2003) 2026.

back to top
Last updated: 09/29/2026
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration